LEADER 02074nam 2200469 450 001 9910813200703321 005 20230126220625.0 010 $a1-4985-7357-6 035 $a(CKB)4100000007122843 035 $a(MiAaPQ)EBC5570881 035 $a(EXLCZ)994100000007122843 100 $a20181219d2018 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCustomized forms of Kurdishness in Turkey $estate rhetoric, locality, and language use /$fCeren S?engu?l 210 1$aLanham, Maryland :$cLexington Books,$d[2018] 210 4$dİ2018 215 $a1 online resource (137 pages) 225 0 $aKurdish societies, politics, and international relations 311 $a1-4985-7356-8 320 $aIncludes bibliographical references and index. 327 $aIntroduction : researching Kurdishness in Turkey -- Abbreviations -- Two "moments of transition" : how state rhetoric plays a role in manifestations of Kurdishness -- Contextualising Kurdishness through localities : everyday experiences of prejudice/discrimination -- Contextualising Kurdishness through language : family environment and neighbourhood -- Conclusion : (re-)shaping Kurdishness from macro to micro -- Appendix : list of the respondents. 330 $aThis book unpacks the diversity of experiences of Kurdishness in Turkey. By doing that, this book fills the gap within the literature on ethnicities. 606 $aKurds$zTurkey$xPolitics and government 606 $aKurds$zTurkey$xSocial conditions 606 $aKurds$zTurkey$xLanguages 607 $aTurkey$xEthnic relations 615 0$aKurds$xPolitics and government. 615 0$aKurds$xSocial conditions. 615 0$aKurds$xLanguages. 676 $a305.891/5970561 700 $aS?engu?l$b Ceren$01709537 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910813200703321 996 $aCustomized forms of Kurdishness in Turkey$94099357 997 $aUNINA LEADER 04002nam 22006495 450 001 9910763595403321 005 20251008140500.0 010 $a3-031-35811-2 024 7 $a10.1007/978-3-031-35811-1 035 $a(MiAaPQ)EBC30881075 035 $a(Au-PeEL)EBL30881075 035 $a(DE-He213)978-3-031-35811-1 035 $a(CKB)28817574700041 035 $a(EXLCZ)9928817574700041 100 $a20231110d2023 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPharmaceutical Formulations for Older Patients /$fedited by Mine Orlu, Fang Liu 205 $a1st ed. 2023. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2023. 215 $a1 online resource (294 pages) 225 1 $aAAPS Advances in the Pharmaceutical Sciences Series,$x2210-738X ;$v51 311 08$aPrint version: Orlu, Mine Pharmaceutical Formulations for Older Patients Cham : Springer International Publishing AG,c2023 9783031358104 327 $aPart 1: Patient-Centric Considerations.-Medicine Optimisation in Older -- Acceptability of drug formulations in older patients and effect on patient adherence -- Geriatric biopharmaceutics -- Excipient safety in older adults -- Part 2: Pharmaceutical Formulations Development for older Patients -- Oral and oromucosal formulation development and in vitro characterisation ? patient-centric approaches for older adults -- Pulmonary drug delivery systems for older people -- Transdermal drug delivery systems for older patients -- Part 3 :Advanced Drug Delivery Systems for Older Patients -- Advanced oral drug delivery systems for older patients -- The ageing microbiome, pharmaceutical considerations and therapeutic opportunities -- Application of 3D printing in geriatric medicines, -- Application of electrospraying and advanced fabrication methods in geriatric medicines -- Vaccine development for older patients. 330 $aPharmaceutical formulation design affects patient acceptability/adherence and pharmacokinetics of the drug. This is particularly important for older patients because of the physiological changes due to ageing and clinical/social circumstances related to medicine taking. This book provides a comprehensive review in the design of formulations to meet the needs of older patients. An overview of the key clinical, social and pharmaceutical factors affecting medication optimization, safety and acceptability in older adults is included, followed by patient-centric considerations including regulatory requirements, dosage form design and human factor studies. Advanced pharmaceutical technologies are discussed for their potential use in older adults such as 3D printing, long-acting oral formulations and novel vaccine technologies. The unique focus of the book will be of interest to pharmaceutical scientists in both industry and academia in searching for better formulations for older patients. 410 0$aAAPS Advances in the Pharmaceutical Sciences Series,$x2210-738X ;$v51 606 $aDrug delivery systems 606 $aPharmaceutical chemistry 606 $aPharmacology 606 $aMedicine$xResearch 606 $aBiology$xResearch 606 $aDrug Delivery 606 $aPharmaceutics 606 $aPharmacology 606 $aBiomedical Research 615 0$aDrug delivery systems. 615 0$aPharmaceutical chemistry. 615 0$aPharmacology. 615 0$aMedicine$xResearch. 615 0$aBiology$xResearch. 615 14$aDrug Delivery. 615 24$aPharmaceutics. 615 24$aPharmacology. 615 24$aBiomedical Research. 676 $a615.70846 700 $aOrlu$b Mine$01439068 701 $aLiu$b Fang$0674440 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910763595403321 996 $aPharmaceutical Formulations for Older Patients$93601295 997 $aUNINA